Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area pi3k akt signaling s6 kinase'

Search results for: 'research area pi3k akt signaling s6 kinase'

Items 1-10 of 48

Page
per page
  1. Tie2 kinase inhibitor
    A5979 Tie2 kinase inhibitor
    Target: Tie-2
    Summary: Tie-2(Tie2 ) inhibitor
      ≥22 mg/mL
  2. Sorafenib
    A3009 Sorafenib
     2 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥23.25 mg/mL
  3. Nilotinib(AMN-107)
    A8232 Nilotinib(AMN-107)
     1 Citation
    Target: Bcr-Abl
    Summary: Bcr-Abl kinase inhibitor,selective
      ≥26.5 mg/mL
  4. NVP-AEW541
    A2278 NVP-AEW541
    Target: Insulin Receptor
    Summary: IGF-IR inhibitor, novel, potent and selective
      ≥22 mg/mL
  5. PP 1
    A8215 PP 1
    Target: Src|EGFR|JAK|ZAP-70
    Summary: Src family tyrosine kinase inhibitor
  6. PF-00562271
    A8320 PF-00562271
    Target: FAK|Pyk2
    Summary: FAK/Pyk2 inhibitor,potent and ATP-competitive
      insoluble in EtOH; insoluble in H2O; ≥11.1 mg/mL
  7. BMS-754807
    A1185 BMS-754807
    Target: Insulin and Insulin-like Receptors
    Summary: IGF-1R/InsR inhibitor,potent and selective
      ≥23.05 mg/mL
  8. PF-562271 HCl
    A8345 PF-562271 HCl
    Target: FAK|Pyk2
    Summary: FAK/Pyk2 inhibitor
      ≥26.35 mg/mL
  9. R788 disodium
    A8332 R788 disodium
    Target: Syk
    Summary: Syk inhibitor,ATP competitive and potent
      ≥62.4 mg/mL
  10. Cediranib (AZD217)
    A1882 Cediranib (AZD217)
    Target: VEGFR
    Summary: VEGFR inhibitor receptor,highly potent
      ≥22.52 mg/mL

Items 1-10 of 48

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
  2. Specificity Selective Remove This Item
  3. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 2item
  2. Axl 3item
  3. ALK 1 item
  4. c-FMS 1 item
  5. c-MET 5item
  6. c-RET 1 item
  7. CSF-1R 2item
  8. EGFR 7item
  9. FAK 2item
  10. FGFR 2item
  11. FLT3 1 item
  12. HER2 3item
  13. IGF1R 3item
  14. ITK 1 item
  15. LRRK2 3item
  16. PDGFR 3item
  17. Pyk2 1 item
  18. Spleen Tyrosine Kinase (Syk) 3item
  19. Src 3item
  20. Tie-2 2item
  21. Trk 2item
  22. VEGFR 7item
Reversibility
  1. Reversible 4item
  2. Irreversible 1 item
Target
  1. Raf 2item
  2. CSF-1R 2item
  3. FLT3 3item
  4. Eph Receptors 1 item
  5. VEGFR 10item
  6. PDGFR 5item
  7. c-Kit 3item
  8. RET 1 item
  9. Bcr-Abl 3item
  10. FGFR 2item
  11. MET 3item
  12. Src 2item
  13. Trk Receptors 1 item
  14. EGFR 7item
  15. FAK 2item
  16. JAK 2item
  17. Syk 3item
  18. ErbB 1 item
  19. c-MET 4item
  20. Pyk2 2item
  21. LRRK2 3item
  22. Insulin and Insulin-like Receptors 2item
  23. ALK 1 item
  24. Tie-2 1 item
  25. Insulin Receptors 1 item
  26. IRG-1R 1 item
  27. ZAP-70 1 item
  28. TAM kinase 1 item
  29. AXL 1 item
  30. c-Fms tyrosine kinase 1 item
  31. Lyn kinase 1 item
  32. ITK 1 item
  33. DCLK2 1 item
  34. tropomyosin receptor kinase 1 item
  35. Insulin Receptor 1 item
Related Disease
  1. Acute Myeloid Leukemia 3item
  2. Adrenocortical Carcinoma 1 item
  3. Bladder Cancer 3item
  4. Bladder Carcinoma 1 item
  5. Breast Cancer 10item
  6. Cancer 34item
  7. Cervical Cancer 1 item
  8. Cholangiocarcinoma 1 item
  9. Clear Cell Renal Cell Carcinoma 1 item
  10. Colon Cancer 2item
  11. Colorectal Cancer 8item
  12. Glioblastoma 4item
  13. Glioma 1 item
  14. Hepatocellular Carcinoma 3item
  15. Leukemia 1 item
  16. Liver Cancer 2item
  17. Lung Cancer 2item
  18. Lung Carcinoma 1 item
  19. Lymphoma 4item
  20. Melanoma 1 item
  21. Multiple Myeloma 2item
  22. Non-small Cell Lung Cancer 3item
  23. Ovarian Cancer 5item
  24. Pancreatic Cancer 7item
  25. Prostate Cancer 5item
  26. Renal Cancer 1 item
  27. Renal Cell Carcinoma 1 item
  28. Rheumatoid Arthritis 2item
  29. Thyroid Cancer 1 item